Ami Organics raises Rs. 400 crores through QIP
The Issue opened on June 18, 2024 and closed on June 21, 2024
The Issue opened on June 18, 2024 and closed on June 21, 2024
Cipla had earlier invested € 15 million in Ethris in 2022
New data on the secondary endpoint shows up to 52.3% of adults with fibrosis stages F1, F2 and F3 had improvement in fibrosis due to MASH
Strategic focus on India aims to make the Swoop® portable MR brain imaging system commercially available in a vast and underserved MRI market
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
The collaboration aims to bolster healthcare entrepreneurship
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
NexGard Spectra is a soft, flavourful monthly chew that kills fleas before they can lay eggs
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
Subscribe To Our Newsletter & Stay Updated